These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin. Marshall JL, Oh J, Chou E, Lee JA, Holmberg J, Burkin DJ, Crosbie-Watson RH. Hum Mol Genet; 2015 Apr 01; 24(7):2011-22. PubMed ID: 25504048 [Abstract] [Full Text] [Related]
4. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Nguyen HH, Jayasinha V, Xia B, Hoyte K, Martin PT. Proc Natl Acad Sci U S A; 2002 Apr 16; 99(8):5616-21. PubMed ID: 11960016 [Abstract] [Full Text] [Related]
5. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG, Wehling-Henricks M. Mol Genet Metab; 2004 Aug 16; 82(4):312-20. PubMed ID: 15308129 [Abstract] [Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS. Exp Physiol; 2014 Apr 16; 99(4):675-87. PubMed ID: 24443351 [Abstract] [Full Text] [Related]
12. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration. Weir AP, Morgan JE, Davies KE. Neuromuscul Disord; 2004 Jan 16; 14(1):19-23. PubMed ID: 14659408 [Abstract] [Full Text] [Related]
13. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, Burkin DJ. J Cell Sci; 2006 Jun 01; 119(Pt 11):2185-95. PubMed ID: 16684813 [Abstract] [Full Text] [Related]
14. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Louboutin JP, Rouger K, Tinsley JM, Halldorson J, Wilson JM. Mol Med; 2001 May 01; 7(5):355-64. PubMed ID: 11474581 [Abstract] [Full Text] [Related]
15. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. D'Arcy CE, Feeney SJ, McLean CA, Gehrig SM, Lynch GS, Smith JE, Cowling BS, Mitchell CA, McGrath MJ. Hum Mol Genet; 2014 Feb 01; 23(3):618-36. PubMed ID: 24087791 [Abstract] [Full Text] [Related]
16. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice. van Putten M, Hulsker M, Young C, Nadarajah VD, Heemskerk H, van der Weerd L, 't Hoen PA, van Ommen GJ, Aartsma-Rus AM. FASEB J; 2013 Jun 01; 27(6):2484-95. PubMed ID: 23460734 [Abstract] [Full Text] [Related]
17. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Nat Med; 1998 Dec 01; 4(12):1441-4. PubMed ID: 9846586 [Abstract] [Full Text] [Related]
18. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, Croci D, Davies KE, Cornelio F, Pozza O, Karpati G, Gilbert R, Mora M. Gene Ther; 2003 May 01; 10(9):750-7. PubMed ID: 12704413 [Abstract] [Full Text] [Related]
19. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Rafael JA, Tinsley JM, Potter AC, Deconinck AE, Davies KE. Nat Genet; 1998 May 01; 19(1):79-82. PubMed ID: 9590295 [Abstract] [Full Text] [Related]
20. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice. Hoyte K, Jayasinha V, Xia B, Martin PT. Am J Pathol; 2004 Feb 01; 164(2):711-8. PubMed ID: 14742274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]